These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 19278989)
1. PGE2 production in oral cancer cell lines is COX-2-dependent. Husvik C; Khuu C; Bryne M; Halstensen TS J Dent Res; 2009 Feb; 88(2):164-9. PubMed ID: 19278989 [TBL] [Abstract][Full Text] [Related]
2. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E(2) pathway in head and neck squamous cell carcinoma. Camacho M; León X; Fernández-Figueras MT; Quer M; Vila L Head Neck; 2008 Sep; 30(9):1175-81. PubMed ID: 18642283 [TBL] [Abstract][Full Text] [Related]
4. Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro. Rathore K; Alexander M; Cekanova M Transl Res; 2014 Aug; 164(2):158-68. PubMed ID: 24631063 [TBL] [Abstract][Full Text] [Related]
6. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. Liu CY; Lai YY; Lo CJ J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127 [TBL] [Abstract][Full Text] [Related]
7. Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase-2-prostaglandin E2 pathway. Kekatpure VD; Singh M; Selvam S; Shetkar G; Hedne NC; Trivedi NP; Siddappa G; Govindan SV; Suresh A; Rangarajan B; Dannenberg AJ; Kuriakose MA Head Neck; 2015 Aug; 37(8):1142-9. PubMed ID: 24771596 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent. Husvik C; Bryne M; Halstensen TS Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase and CD147 expression in oral squamous cell carcinoma patient samples and cell lines. Nasry WHS; Wang H; Jones K; Tesch M; Rodriguez-Lecompte JC; Martin CK Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Oct; 128(4):400-410.e3. PubMed ID: 31350224 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
11. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Banning A; Florian S; Deubel S; Thalmann S; Müller-Schmehl K; Jacobasch G; Brigelius-Flohé R Antioxid Redox Signal; 2008 Sep; 10(9):1491-500. PubMed ID: 18479189 [TBL] [Abstract][Full Text] [Related]
12. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Al-Fayez M; Cai H; Tunstall R; Steward WP; Gescher AJ Cancer Chemother Pharmacol; 2006 Dec; 58(6):816-25. PubMed ID: 16552572 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
14. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
15. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Nah SS; Choi IY; Lee CK; Oh JS; Kim YG; Moon HB; Yoo B Rheumatology (Oxford); 2008 Apr; 47(4):425-31. PubMed ID: 18285354 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Yu L; Wu WK; Li ZJ; Li HT; Wu YC; Cho CH Int J Cancer; 2009 Dec; 125(11):2540-6. PubMed ID: 19623651 [TBL] [Abstract][Full Text] [Related]
17. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells. Noguchi K; Shitashige M; Ishikawa I J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity. Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847 [TBL] [Abstract][Full Text] [Related]
19. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. Yucel-Lindberg T; Ahola H; Carlstedt-Duke J; Modéer T Biochem Biophys Res Commun; 1999 Apr; 257(2):528-32. PubMed ID: 10198245 [TBL] [Abstract][Full Text] [Related]
20. [Epidermal growth factor stimulates the proliferation of human esophageal squamous cell carcinoma HKESC-1 cells by increasing COX-2 expression]. Yu L; Cho CH; Liu SW Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1323-6. PubMed ID: 21868314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]